Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral tranexamic acid for the treatment of melasma: a review. Dermatol Surg. 2018; 44(6): 814-825.

https://doi.org/10.1097/DSS.0000000000001518

Kim HJ, Moon SH, Cho SH, Lee JD, Sung Kim H. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol. 2017; 97(6-7): 776-781.

https://doi.org/10.2340/00015555-2668

Del Rosario E, Florez-Pollack S, Zapata Jr L, Hernandez K, Tovar-Garza A, Rodrigues M, et al. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol. 2018; 78(2): 363-369.

https://doi.org/10.1016/j.jaad.2017.09.053

Sharma R, Mahajan VK, Mehta KS, Chauhan PS, Rawat R, Shiny TN. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol. 2017; 42(7): 728-734.

https://doi.org/10.1111/ced.13164

Wang JV, Jhawar N, Saedi N. Tranexamic Acid for Melasma: Evaluating the Various Formulations. J Clinical Aesthetic Dermatol. 2019; 12(8): E73-E74.

Tadir Y, Gaspar A, Lev-Sagie A, Alexiades M, Alinsod R, Bader A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med. 2017; 49(2):137-159.

https://doi.org/10.1002/lsm.22637

González Isaza P, Jaguszewska K, Cardona JL, Lukaszuk M. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J. 2018; 29(2): 211-215.

https://doi.org/10.1007/s00192-017-3352-1

Zerbinati N, Serati M, Origoni M, Candiani M, Lannitti T. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015; 30(1): 429-436.

https://doi.org/10.1007/s10103-014-1677-2

Sokol ER, Karram M. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause. 2016; 23(10): 1102-1107.

https://doi.org/10.1097/GME.0000000000000700

Agarwal P, Rashighi M, Essien KI, Richmond J, Randall L, Pazoki-Toroudi H, et al. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol. 2015; 135(4): 1080-1088.

https://doi.org/10.1038/jid.2014.529

Vanderweil SG, Amano S, Ko WC, Richmond J, Kelley M, Makredes Senna M, et al. A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo. J Am Acad Dermatol. 2017; 76(1):150-151.

https://doi.org/10.1016/j.jaad.2016.06.015

Iraji F, Banihashemi SH, Faghihi G, Shahmorad Z, Tajmirriahi N, Bokaie Jazi S. A comparison of betamethasone valerate 0.1% cream twice daily plus oral simvastatin versus betamethasone valerate 0.1% cream alone in the treatment of vitiligo patients. Adv Biomed Res. 2017; 6:34.

https://doi.org/10.4103/2277-9175.203159

Armario-Hita JC, Pereyra-Rodriguez J, Silvestre JF, Ruiz -Villaverde R, Valero A, Izu-Belloso R, et al. Treatment of moderate-to-severe Atopic dermatitis with dupilumab in real clinical practice. A multicentre, retrospective case series. B J Dermatol. 2019: 181(5): 1072-1074

https://doi.org/10.1111/bjd.18041

Seegräber M, Srour J, Walter A, Knop M, Wollenberg A. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol. 2018; 11(5): 467- 474.

https://doi.org/10.1080/17512433.2018.1449642

Gooderham MJ, Hong HC, Eshtiaghi P, Papp K. Dupilumab: A review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018; 78(3): S28-S36.

https://doi.org/10.1016/j.jaad.2017.12.022

Pérez Atamoros FM, Alcalá Pérez D, Asz Sigall D, Ávila Romay A, Barba Gastelum J , de la Peña Salcedo J. Evidence-based treatment for gynoid lipodystrophy: A review of the recent literature. J Cosmet Dermatology. 2018; 17(6):977-983.

https://doi.org/10.1111/jocd.12555

Zerini I, Sisti A, Cuomo R, Ciappi S, Russo F, Brandi C,et al. Cellulite treatment: a comprehensive literature review. J Cosmet Dermatol. 2015; 14(3): 224-240.

https://doi.org/10.1111/jocd.12154

Rossi AM, Katz BE. A modern approach to the treatment of cellulite. Dermatol Clin, 2014; 32(1): 51-59.

https://doi.org/10.1016/j.det.2013.09.005

Zouboulis CC, Dessinioti C, Tsatsou F, Gollnick H. Anti-acne drugs in phase 1 and 2 clinical trials. Expert Opin Invest Drugs. 2017; 26(7): 813-823.

https://doi.org/10.1080/13543784.2017.1337745

Tan J, Thiboutot D, Popp G, Gooderham M, Lynde C, Del Rosso J, et al. Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019; 80(6): 1691-1699.

https://doi.org/10.1016/j.jaad.2019.02.044

Trifu V, Tiplica GS, Naumescu E, Zalupca L, Moro L, Celasco G. Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, doubleblind comparative study vs. placebo and tretinoin 0· 05% cream. Br J Dermatol. 2011; 165(1):177-183.

https://doi.org/10.1111/j.1365-2133.2011.10332.x

Videira IF, Moura DF, Magina S. Mechanisms regulating melanogenesis. An Bras Dermatol. 2013; 88(1): 76-83.

https://doi.org/10.1590/S0365-05962013000100009

D'Mello SA, Finlay GJ, Baguley BC, Askarian-Amiri M. Signaling pathways in melanogenesis. Int J Mol Sci. 2016; 17(7):1144

https://doi.org/10.3390/ijms17071144

Yuan XH, Jin ZH. Paracrine regulation of melanogenesis. Br J Dermatol. 2018; 178(3): 632-639.

https://doi.org/10.1111/bjd.15651

Eagleston LRM, Kalani NK, Patel RR, Flaten H, Dunnick C, DellaValle R. Cannabinoids in dermatology: A scoping review. Dermatol Online J. 2018; 24(6)

Moya AI, Ruiz-Rodríguez R. Eficacia y seguridad de los cannabinoides tópicos en dermatología. Piel. 2019; 34(5): 313-315.

https://doi.org/10.1016/j.piel.2018.07.011

Caterina MJ. TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation. ACS Chem Neurosci. 2014: 5(11): 1107-1116.

https://doi.org/10.1021/cn5000919

Yélamos O, Braun RP, Liopyris K, Wolner Z, Kerl K, Gerami P,et al. Dermoscopy and dermatopathology correlates of cutaneous neoplasms. J Am Acad Dermatol. 2019; 80(2): 341-363.

https://doi.org/10.1016/j.jaad.2018.07.073

Lallas A, Apalla Z, Ioannides D, Lazaridou E, Kyrgidis A, Broganelli P, et al. Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society. Br J Dermatol. 2017; 177(3): 645-655.

https://doi.org/10.1111/bjd.15339

Yélamos O, Navarrete-Dechent C, Marchetti MA, Rogers T, Apalla Z, Bahadoran P, et al. Clinical and dermoscopic features of cutaneous BAP1- inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society. J Am Acad Dermatol. 2019; 80(6):1585-1593.

https://doi.org/10.1016/j.jaad.2018.09.014